308 related articles for article (PubMed ID: 31289964)
1. Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement.
Degnan AJ; Ho-Fung VM; Ahrens-Nicklas RC; Barrera CA; Serai SD; Wang DJ; Ficicioglu C
Insights Imaging; 2019 Jul; 10(1):70. PubMed ID: 31289964
[TBL] [Abstract][Full Text] [Related]
2. The Spectrum of Neurological Manifestations Associated with Gaucher Disease.
Roshan Lal T; Sidransky E
Diseases; 2017 Mar; 5(1):. PubMed ID: 28933363
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations and management of Gaucher disease.
Linari S; Castaman G
Clin Cases Miner Bone Metab; 2015; 12(2):157-64. PubMed ID: 26604942
[TBL] [Abstract][Full Text] [Related]
4. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease.
Nagral A
J Clin Exp Hepatol; 2014 Mar; 4(1):37-50. PubMed ID: 25755533
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.
Mikosch P; Kohlfürst S; Gallowitsch HJ; Kresnik E; Lind P; Mehta AB; Hughes DA
Nuklearmedizin; 2008; 47(6):239-47. PubMed ID: 19057797
[TBL] [Abstract][Full Text] [Related]
7. Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.
Grabowski GA; Andria G; Baldellou A; Campbell PE; Charrow J; Cohen IJ; Harris CM; Kaplan P; Mengel E; Pocovi M; Vellodi A
Eur J Pediatr; 2004 Feb; 163(2):58-66. PubMed ID: 14677061
[TBL] [Abstract][Full Text] [Related]
8. Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.
Serai SD; Naidu AP; Andrew Burrow T; Prada CE; Xanthakos S; Towbin AJ
Mol Genet Metab; 2018 Mar; 123(3):357-363. PubMed ID: 29361370
[TBL] [Abstract][Full Text] [Related]
9. An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease.
Hollak CE
Core Evid; 2012; 7():15-20. PubMed ID: 22654679
[TBL] [Abstract][Full Text] [Related]
10. Jaw involvement in Gaucher disease: a not-so-uncommon feature of a rare disease.
D'Amore S; Kumar N; Ramaswami U
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34785512
[TBL] [Abstract][Full Text] [Related]
11. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.
Hollak C; Maas M; Akkerman E; den Heeten A; Aerts H
Blood Cells Mol Dis; 2001; 27(6):1005-12. PubMed ID: 11831867
[TBL] [Abstract][Full Text] [Related]
12. Gaucher disease.
Guggenbuhl P; Grosbois B; Chalès G
Joint Bone Spine; 2008 Mar; 75(2):116-24. PubMed ID: 17996473
[TBL] [Abstract][Full Text] [Related]
13. Gaucher disease: a diagnostic challenge for internists.
Cassinerio E; Graziadei G; Poggiali E
Eur J Intern Med; 2014 Feb; 25(2):117-24. PubMed ID: 24090739
[TBL] [Abstract][Full Text] [Related]
14. Imaging and quantifying skeletal involvement in Gaucher disease.
Maas M; Poll LW; Terk MR
Br J Radiol; 2002; 75 Suppl 1():A13-24. PubMed ID: 12036829
[TBL] [Abstract][Full Text] [Related]
15. Skeletal aspects of Gaucher disease: a review.
Wenstrup RJ; Roca-Espiau M; Weinreb NJ; Bembi B
Br J Radiol; 2002; 75 Suppl 1():A2-12. PubMed ID: 12036828
[TBL] [Abstract][Full Text] [Related]
16. Gaucher disease: a lysosomal neurodegenerative disorder.
Huang WJ; Zhang X; Chen WW
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1219-26. PubMed ID: 25912581
[TBL] [Abstract][Full Text] [Related]
17. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
18. Imaging of Gaucher disease.
Simpson WL; Hermann G; Balwani M
World J Radiol; 2014 Sep; 6(9):657-68. PubMed ID: 25276309
[TBL] [Abstract][Full Text] [Related]
19. Small Bowel Mucosal Involvement and Mesenteric Mass Formation in a Young Female with Type 3 Gaucher Disease. A Case Report.
Emanuel AJ; Holman N; Presnell SE; Welsh CT; Pai S; Sun S
J Gastrointestin Liver Dis; 2018 Dec; 27(4):459-463. PubMed ID: 30574629
[TBL] [Abstract][Full Text] [Related]
20. [Gaucher disease: clinical, genetic and therapeutic aspects].
Germain DP
Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
